UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lurbinectedin Specifically Triggers the Degradation of Phosphorylated RNA Polymerase II and the Formation of DNA Breaks in Cancer Cells

Molecular cancer therapeutics, 2016-10, Vol.15 (10), p.2399-2412

2016

Volltextzugriff (PDF)

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (6), p.2235-2244

2010

Volltextzugriff (PDF)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

Disease models & mechanisms, 2016-12, Vol.9 (12), p.1461-1471

2016

Volltextzugriff (PDF)

Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound

Marine drugs, 2013-03, Vol.11 (3), p.944-959

2013

Volltextzugriff (PDF)

Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin

Scientific reports, 2018-06, Vol.8 (1), p.8616-19, Article 8616

2018

Volltextzugriff (PDF)

Editorial: Ageing and Carcinogenesis

Frontiers in oncology, 2022-02, Vol.12, p.849127-849127

2022

Volltextzugriff (PDF)

Use of deep learning frameworks to detect super-responder and super-survivor stage IV squamous non-small-cell lung cancer (NSCLC) patients treated with a gemcitabine and cisplatin combination

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1548-1548

2021

Volltextzugriff (PDF)

Predicting disease progression and mortality in metastatic colorectal cancer patients (mCRC) through an artificial intelligence-based analytical tool

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1549-1549

2021

Volltextzugriff (PDF)

Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus

Cancer research (Chicago, Ill.), 2016-11, Vol.76 (22), p.6657-6668

2016

Volltextzugriff (PDF)

Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine

International journal of cancer, 2002-02, Vol.97 (4), p.439-445

2002

Volltextzugriff (PDF)

Development and validation of MOSPROC, an easily applicable predictive score of mortality for patients with prostate cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13598-e13598

2024

Volltextzugriff (PDF)

Identification of genes related to PD-L1 expression in non-small cell lung cancer (NSCLC) tumor samples by GFPrint, a machine learning framework (MLF)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13600-e13600

2024

Volltextzugriff (PDF)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Oncotarget, 2015-08, Vol.6 (22), p.18875-18890

2015

Volltextzugriff (PDF)

Profiling of clinically relevant subgroups of asymptomatic or mild-symptomatic metastatic castration-resistant prostate cancer (mCRPC) patients using PSA and testosterone levels and deep learning

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17032-e17032

2022

Volltextzugriff (PDF)

A deep learning framework (DLF) to identify clinical predictors of disease progression and mortality in metastatic castration-resistant prostate cancer (mCRPC) patients treated with docetaxel/prednisone (DP)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13550-e13550

2022

Volltextzugriff (PDF)

Development and validation of a predictive score to identify K-Ras wild-type (WT) metastatic colorectal cancer (mCRC) patients who are likely to benefit from Panitumumab (P) treatment

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15526-e15526

2022

Volltextzugriff (PDF)

p53 as a target for anti-cancer drug development

Critical reviews in oncology/hematology, 2006-06, Vol.58 (3), p.190-207

2006

Volltextzugriff (PDF)

Molecular pharmacology and antitumor activity of Zalypsis ® in several human cancer cell lines

Biochemical pharmacology, 2009-07, Vol.78 (2), p.162-170

2009

Volltextzugriff (PDF)

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts

Oncotarget, 2019-04, Vol.10 (28), p.2709-2721

2019

Volltextzugriff (PDF)

βIII-Tubulin is required for interphase microtubule dynamics in untransformed human mammary epithelial cells

European journal of cell biology, 2011-10, Vol.90 (10), p.872-878

2011

Volltextzugriff (PDF)

The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia

Haematologica (Roma), 2005-12, Vol.90 (12), p.1699

2005

Volltextzugriff (PDF)

p21(Cip1) regulates cell-substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells

European journal of cell biology, 2011-08, Vol.90 (8), p.631-641

2011

Volltextzugriff (PDF)

Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine

British journal of haematology, 2003-07, Vol.122 (1), p.53-60

2003

Volltextzugriff (PDF)

p21 Cip1 regulates cell–substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells

European journal of cell biology, 2011-08, Vol.90 (8), p.631-641

2011

Volltextzugriff (PDF)

Influence of p53 and p21WAF1 expression on sensitivity of cancer cells to cladribine

Biochemical pharmacology, 2003, Vol.65 (1), p.121-129

2003

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Animals
(18)
Female
(15)
Oncology
(14)
Apoptosis
(12)
Cell Line, Tumor
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Antineoplastic Agents - Pharmacology
(10)
Mice
(9)
Drug Resistance
(8)
Hematology
(8)
Male
(8)
Neoplasms - Drug Therapy
(8)
Pharmacology & Pharmacy
(8)
Pharmacology. Drug Treatments
(8)
Antineoplastic Agents
(7)
Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lurbinectedin Specifically Triggers the Degradation of Phosphorylated RNA Polymerase II and the Formation of DNA Breaks in Cancer Cells

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound

Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin

Editorial: Ageing and Carcinogenesis

Use of deep learning frameworks to detect super-responder and super-survivor stage IV squamous non-small-cell lung cancer (NSCLC) patients treated with a gemcitabine and cisplatin combination

Predicting disease progression and mortality in metastatic colorectal cancer patients (mCRC) through an artificial intelligence-based analytical tool

Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus

Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine

Development and validation of MOSPROC, an easily applicable predictive score of mortality for patients with prostate cancer

Identification of genes related to PD-L1 expression in non-small cell lung cancer (NSCLC) tumor samples by GFPrint, a machine learning framework (MLF)

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Profiling of clinically relevant subgroups of asymptomatic or mild-symptomatic metastatic castration-resistant prostate cancer (mCRPC) patients using PSA and testosterone levels and deep learning

A deep learning framework (DLF) to identify clinical predictors of disease progression and mortality in metastatic castration-resistant prostate cancer (mCRPC) patients treated with docetaxel/prednisone (DP)

Development and validation of a predictive score to identify K-Ras wild-type (WT) metastatic colorectal cancer (mCRC) patients who are likely to benefit from Panitumumab (P) treatment

p53 as a target for anti-cancer drug development

Molecular pharmacology and antitumor activity of Zalypsis ® in several human cancer cell lines

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts

βIII-Tubulin is required for interphase microtubule dynamics in untransformed human mammary epithelial cells

The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia

p21(Cip1) regulates cell-substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells

Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine

p21 Cip1 regulates cell–substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells

Influence of p53 and p21WAF1 expression on sensitivity of cancer cells to cladribine

Suchergebnisse filtern